{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:56:46Z","timestamp":1792112206029,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2024-00400118"],"award-info":[{"award-number":["RS-2024-00400118"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["NRF-2022M3H4A4085936"],"award-info":[{"award-number":["NRF-2022M3H4A4085936"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parkinson\u2019s disease (PD) affects motor and non-motor systems; however, retinal changes and their molecular basis are not well understood. Using a transgenic mouse model overexpressing A53T-mutant human \u03b1-synuclein, we examined retinal function, structure, and proteomics at 6- and 16 months. Early retinal dysfunction was detected by a reduction in scotopic oscillatory potential amplitudes on electroretinography. Optical coherence tomography showed early thinning of the retinal nerve fiber layer\/ganglion cell layer, and photoreceptor layer, accompanied by thickening of the inner plexiform layer. Phosphorylated \u03b1-synuclein accumulation, increased glial fibrillary acidic protein, and loss of the ribbon synapse protein CtBP2 were observed. Proteomic profiling revealed stage-dependent alterations involving \u03b1-synuclein, oxidative stress markers, and crystallins. Network analysis showed progression from \u03b1-synuclein-associated disruption to inflammation and metabolic remodeling. These results highlight retinal alterations as early indicators of PD neurodegeneration and provide mechanistic insights into the molecular events that precede neuronal loss.<\/jats:p>","DOI":"10.1038\/s41531-026-01261-7","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:19:19Z","timestamp":1768479559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Early retinal synaptic dysfunction and proteomic remodeling precede neurodegeneration in a Parkinson\u2019s disease model"],"prefix":"10.1038","volume":"12","author":[{"given":"Chae-Eun","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haesol","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ki","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunseung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Hee","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Keun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Yul","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Rae","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Woo","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"1261_CR1","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.cortex.2008.11.010","volume":"45","author":"AL Bartels","year":"2009","unstructured":"Bartels, A. L. & Leenders, K. L. Parkinson\u2019s disease: the syndrome, the pathogenesis and pathophysiology. Cortex 45, 915\u2013921 (2009).","journal-title":"Cortex"},{"key":"1261_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.02.014","volume":"40","author":"MS Ekker","year":"2017","unstructured":"Ekker, M. S. et al. Ocular and visual disorders in Parkinson\u2019s disease: common but frequently overlooked. Parkinsonism Relat. Disord. 40, 1\u201310 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1261_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10633-015-9503-0","volume":"131","author":"B Nowacka","year":"2015","unstructured":"Nowacka, B., Lubinski, W., Honczarenko, K., Potemkowski, A. & Safranow, K. Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson\u2019s disease (PD). Doc. Ophthalmol. 131, 95\u2013104 (2015).","journal-title":"Doc. Ophthalmol."},{"key":"1261_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.parkreldis.2022.06.018","volume":"101","author":"LGM Mello","year":"2022","unstructured":"Mello, L. G. M. et al. Electroretinography reveals retinal dysfunction in Parkinson\u2019s disease despite normal high-resolution optical coherence tomography findings. Parkinsonism Relat. Disord. 101, 90\u201395 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1261_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41582-022-00618-9","volume":"18","author":"JY Lee","year":"2022","unstructured":"Lee, J. Y. et al. Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease. Nat. Rev. Neurol. 18, 203\u2013220 (2022).","journal-title":"Nat. Rev. Neurol."},{"key":"1261_CR6","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/ene.14613","volume":"28","author":"WC Zhou","year":"2021","unstructured":"Zhou, W. C., Tao, J. X. & Li, J. Optical coherence tomography measurements as potential imaging biomarkers for Parkinson\u2019s disease: a systematic review and meta-analysis. Eur. J. Neurol. 28, 763\u2013774 (2021).","journal-title":"Eur. J. Neurol."},{"key":"1261_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jns.2015.05.007","volume":"355","author":"J Chorostecki","year":"2015","unstructured":"Chorostecki, J. et al. Characterization of retinal architecture in Parkinson\u2019s disease. J. Neurol. Sci. 355, 44\u201348 (2015).","journal-title":"J. Neurol. Sci."},{"key":"1261_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.533375","volume":"11","author":"C Rascuna","year":"2020","unstructured":"Rascuna, C. et al. Retinal thickness and microvascular pattern in early Parkinson\u2019s disease. Front. Neurol. 11, 533375 (2020).","journal-title":"Front. Neurol."},{"key":"1261_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10072-018-3244-2","volume":"39","author":"M Unlu","year":"2018","unstructured":"Unlu, M., Gulmez Sevim, D., Gultekin, M. & Karaca, C. Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson\u2019s disease. Neurol. Sci. 39, 533\u2013541 (2018).","journal-title":"Neurol. Sci."},{"key":"1261_CR10","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00702-025-02918-y","volume":"132","author":"M Campagnolo","year":"2025","unstructured":"Campagnolo, M. et al. Optical coherence tomography reveals retinal structural abnormalities in alpha-synucleinopathies: insights from the Padua-CESNE cohort. J. Neural Transm. 132, 1013\u20131022 (2025).","journal-title":"J. Neural Transm."},{"key":"1261_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48388-7","volume":"9","author":"MS Sung","year":"2019","unstructured":"Sung, M. S. et al. Inner retinal thinning as a biomarker for cognitive impairment in de novo Parkinson\u2019s disease. Sci. Rep. 9, 11832 (2019).","journal-title":"Sci. Rep."},{"key":"1261_CR12","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s10792-018-0934-y","volume":"39","author":"S Hasanov","year":"2019","unstructured":"Hasanov, S. et al. Functional and morphological assessment of ocular structures and follow-up of patients with early-stage Parkinson\u2019s disease. Int. Ophthalmol. 39, 1255\u20131262 (2019).","journal-title":"Int. Ophthalmol."},{"key":"1261_CR13","doi-asserted-by":"publisher","first-page":"e1003","DOI":"10.1212\/WNL.0000000000006157","volume":"91","author":"J Ahn","year":"2018","unstructured":"Ahn, J. et al. Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease. Neurology 91, e1003\u2013e1012 (2018).","journal-title":"Neurology"},{"key":"1261_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/JPD-171184","volume":"8","author":"LJ Ma","year":"2018","unstructured":"Ma, L. J. et al. Progressive changes in the retinal structure of patients with Parkinson\u2019s disease. J. Parkinsons Dis. 8, 85\u201392 (2018).","journal-title":"J. Parkinsons Dis."},{"key":"1261_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.106872","volume":"208","author":"V Soto Linan","year":"2025","unstructured":"Soto Linan, V. et al. Early detection of Parkinson\u2019s disease: retinal functional impairments as potential biomarkers. Neurobiol. Dis. 208, 106872 (2025).","journal-title":"Neurobiol. Dis."},{"key":"1261_CR16","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1016\/S0042-6989(97)00129-6","volume":"37","author":"MB Djamgoz","year":"1997","unstructured":"Djamgoz, M. B., Hankins, M. W., Hirano, J. & Archer, S. N. Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vis. Res. 37, 3509\u20133529 (1997).","journal-title":"Vis. Res."},{"key":"1261_CR17","doi-asserted-by":"publisher","unstructured":"Tran, K. K. N. et al. Levodopa rescues retinal function in the transgenic A53T alpha-synuclein model of Parkinson\u2019s disease. Biomedicines 12 https:\/\/doi.org\/10.3390\/biomedicines12010130 (2024).","DOI":"10.3390\/biomedicines12010130"},{"key":"1261_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40035-023-00348-y","volume":"12","author":"X Sanchez-Saez","year":"2023","unstructured":"Sanchez-Saez, X., Ortuno-Lizaran, I., Sanchez-Castillo, C., Lax, P. & Cuenca, N. Starburst amacrine cells, involved in visual motion perception, loose their synaptic input from dopaminergic amacrine cells and degenerate in Parkinson\u2019s disease patients. Transl. Neurodegener. 12, 17 (2023).","journal-title":"Transl. Neurodegener."},{"key":"1261_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1146979","volume":"17","author":"KKN Tran","year":"2023","unstructured":"Tran, K. K. N. et al. Retinal alpha-synuclein accumulation correlates with retinal dysfunction and structural thinning in the A53T mouse model of Parkinson\u2019s disease. Front. Neurosci. 17, 1146979 (2023).","journal-title":"Front. Neurosci."},{"key":"1261_CR20","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ajpath.2024.01.017","volume":"194","author":"T Xu","year":"2024","unstructured":"Xu, T. et al. Abnormal alpha-synuclein aggregates cause synaptic- and microcircuit-specific deficits in the retinal rod pathway. Am. J. Pathol. 194, 796\u2013809 (2024).","journal-title":"Am. J. Pathol."},{"key":"1261_CR21","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ana.25897","volume":"88","author":"I Ortuno-Lizaran","year":"2020","unstructured":"Ortuno-Lizaran, I. et al. Dopaminergic retinal cell loss and visual dysfunction in Parkinson disease. Ann. Neurol. 88, 893\u2013906 (2020).","journal-title":"Ann. Neurol."},{"key":"1261_CR22","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1016\/j.visres.2004.06.009","volume":"44","author":"R Inzelberg","year":"2004","unstructured":"Inzelberg, R., Ramirez, J. A., Nisipeanu, P. & Ophir, A. Retinal nerve fiber layer thinning in Parkinson disease. Vis. Res. 44, 2793\u20132797 (2004).","journal-title":"Vis. Res."},{"key":"1261_CR23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/archophthalmol.2009.106","volume":"127","author":"ME Hajee","year":"2009","unstructured":"Hajee, M. E. et al. Inner retinal layer thinning in Parkinson disease. Arch. Ophthalmol. 127, 737\u2013741 (2009).","journal-title":"Arch. Ophthalmol."},{"key":"1261_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-023-03373-6","volume":"23","author":"R Elanwar","year":"2023","unstructured":"Elanwar, R. et al. Retinal functional and structural changes in patients with Parkinson\u2019s disease. BMC Neurol. 23, 330 (2023).","journal-title":"BMC Neurol."},{"key":"1261_CR25","doi-asserted-by":"publisher","first-page":"e1581","DOI":"10.1212\/WNL.0000000000207727","volume":"101","author":"SK Wagner","year":"2023","unstructured":"Wagner, S. K. et al. Retinal optical coherence tomography features associated with incident and prevalent Parkinson disease. Neurology 101, e1581\u2013e1593 (2023).","journal-title":"Neurology"},{"key":"1261_CR26","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fnins.2020.00862","volume":"14","author":"JKH Lim","year":"2020","unstructured":"Lim, J. K. H. et al. Retinal functional and structural changes in the 5xFAD mouse model of Alzheimer\u2019s disease. Front. Neurosci. 14, 862 (2020).","journal-title":"Front. Neurosci."},{"key":"1261_CR27","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/mds.27392","volume":"33","author":"I Ortuno-Lizaran","year":"2018","unstructured":"Ortuno-Lizaran, I. et al. Phosphorylated alpha-synuclein in the retina is a biomarker of Parkinson\u2019s disease pathology severity. Mov. Disord. 33, 1315\u20131324 (2018).","journal-title":"Mov. Disord."},{"key":"1261_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50189-0","volume":"15","author":"C Fu","year":"2024","unstructured":"Fu, C. et al. Mutant mice with rod-specific VPS35 deletion exhibit retinal alpha-synuclein pathology-associated degeneration. Nat. Commun. 15, 5970 (2024).","journal-title":"Nat. Commun."},{"key":"1261_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.07.004","volume":"74","author":"RL Pfeiffer","year":"2020","unstructured":"Pfeiffer, R. L., Marc, R. E. & Jones, B. W. Persistent remodeling and neurodegeneration in late-stage retinal degeneration. Prog. Retin Eye Res. 74, 100771 (2020).","journal-title":"Prog. Retin Eye Res."},{"key":"1261_CR30","doi-asserted-by":"publisher","unstructured":"Caramiello, A. M. & Pirota, V. Novel therapeutic horizons: SNCA targeting in Parkinson\u2019s disease. Biomolecules 14 https:\/\/doi.org\/10.3390\/biom14080949 (2024).","DOI":"10.3390\/biom14080949"},{"key":"1261_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111253","volume":"27","author":"Q He","year":"2024","unstructured":"He, Q. et al. Early synaptic dysfunction of striatal parvalbumin interneurons in a mouse model of Parkinson\u2019s disease. iScience 27, 111253 (2024).","journal-title":"iScience"},{"key":"1261_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.brainres.2013.07.025","volume":"1531","author":"AC Lanoue","year":"2013","unstructured":"Lanoue, A. C., Blatt, G. J. & Soghomonian, J. J. Decreased parvalbumin mRNA expression in dorsolateral prefrontal cortex in Parkinson\u2019s disease. Brain Res. 1531, 37\u201347 (2013).","journal-title":"Brain Res."},{"key":"1261_CR33","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s12031-018-1102-6","volume":"65","author":"Y Fan","year":"2018","unstructured":"Fan, Y. & Xiao, S. Progression rate associated peripheral blood biomarkers of Parkinson\u2019s disease. J. Mol. Neurosci. 65, 312\u2013318 (2018).","journal-title":"J. Mol. Neurosci."},{"key":"1261_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.739918","volume":"12","author":"H Dai","year":"2021","unstructured":"Dai, H., Wang, L., Li, L., Huang, Z. & Ye, L. Metallothionein 1: a new spotlight on inflammatory diseases. Front. Immunol. 12, 739918 (2021).","journal-title":"Front. Immunol."},{"key":"1261_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.exer.2013.08.001","volume":"116","author":"JP Templeton","year":"2013","unstructured":"Templeton, J. P. et al. A crystallin gene network in the mouse retina. Exp. Eye Res. 116, 129\u2013140 (2013).","journal-title":"Exp. Eye Res."},{"key":"1261_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.641999","volume":"12","author":"F Wang","year":"2021","unstructured":"Wang, F. et al. alphaB-crystallin alleviates endotoxin-induced retinal inflammation and inhibits microglial activation and autophagy. Front. Immunol. 12, 641999 (2021).","journal-title":"Front. Immunol."},{"key":"1261_CR37","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.exer.2010.11.008","volume":"92","author":"PE Fort","year":"2011","unstructured":"Fort, P. E. & Lampi, K. J. New focus on alpha-crystallins in retinal neurodegenerative diseases. Exp. Eye Res. 92, 98\u2013103 (2011).","journal-title":"Exp. Eye Res."},{"key":"1261_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.984338","volume":"13","author":"N Zhao","year":"2022","unstructured":"Zhao, N., Quicksall, Z., Asmann, Y. W. & Ren, Y. Network approaches for omics studies of neurodegenerative diseases. Front. Genet. 13, 984338 (2022).","journal-title":"Front. Genet."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01261-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01261-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01261-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T14:22:45Z","timestamp":1771251765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01261-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1261"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01261-7","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}